Page last updated: 2024-10-29

irsogladine and Intestinal Polyps

irsogladine has been researched along with Intestinal Polyps in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Intestinal Polyps: Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.

Research Excerpts

ExcerptRelevanceReference
"Treatment with irsogladine maleate at doses of 5 and 50 ppm significantly reduced the number of intestinal polyps to 69% and 66% of the untreated control value, respectively."1.43Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice. ( Fujii, G; Fujimoto, K; Fukai, F; Hamoya, T; Miyamoto, S; Miyoshi, N; Mutoh, M; Onuma, W; Tomono, S; Wakabayashi, K, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Onuma, W1
Tomono, S1
Miyamoto, S1
Fujii, G1
Hamoya, T1
Fujimoto, K1
Miyoshi, N1
Fukai, F1
Wakabayashi, K1
Mutoh, M1

Other Studies

1 other study available for irsogladine and Intestinal Polyps

ArticleYear
Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice.
    Oncotarget, 2016, Feb-23, Volume: 7, Issue:8

    Topics: Animals; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Disea

2016